Gabrio Bassotti, Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Italy

Vincenzo Villanacci, 2^nd Pathology Section, Spedali Civili, Brescia, Italy

Correspondence to: Dr. Gabrio Bassotti, Clinica di Gastroenterologia ed Epatologia, Via Enrico Dal Pozzo, Padiglione W, Perugia 06100, Italy. gabassot@tin.it

Telephone: +39-75-5783268  Fax: +39-75-5847570

Received: 2006-03-17           Accepted: 2006-03-27

Abstract

Slow transit constipation has been traditionally considered and classified as a functional disorder. However, clinical and manometric evidence has been accumulating that suggests how most of the motility alterations in STC might be considered of neuropathic type.In addition, further investigations showed that subtle alterations of the enteric nervous system, not evident to conventional histological examination, may be present in these patients. In the present article we will discuss these evidences, and will try to put them in relation with the abnormal motor function of the large bowel documented in this pathological condition.

© 2006 The WJG Press. All rights reserved.

Key words: Constipation; Enteric neuropathy; Functional disorders; Slow transit

Bassotti G, Villanacci V. Slow transit constipation: A functional disorder becomes an enteric neuropathy. World J Gastroenterol 2006; 12(29): 4609-4613

 http://www.wjgnet.com/1007-9327/12/4609.asp

INTRODUCTION

In gastroenterology practice, the most frequently encountered disorders are represented by those related to an abnormal function of the abdominal viscera, the so-called functional diseases^[1,2]. The term “functional” defines several variable combinations of chronic or recurrent gastrointestinal symptoms that do not have an identified underlying pathophysiology^[3], and that are often also labelled as “idiopathic”. Thus, the definition of functional relies on the exclusion of an organic disease, and it is consequently thought to be related to abnormalities of its physiological properties or functions.

Among the so-called functional disorders, one of the most common is functional constipation, whose diagnostic criteria according to Rome Ⅱ classification^[4] are reported in Table 1. Patients with functional constipation may be further classified in three subgroups: normal transit constipation, disorders of defecatory or rectal evacuation (outlet obstruction), and slow transit constipation (STC)^[5,6]. This latter condition affects mainly women, it is characterized by an often intractable constipation , a heavily delayed colonic transit up to true colonic inertia^[7,8], and it is usually attributed to disorders of colonic motor function^[9,10]. Indeed, several abnormal motor aspects have been described in STC, such as alterations of rectosigmoid contractile activity^[11], decreased colonic propulsive function^[12,13], abnormal response to food ingestion^[14,15], and overall reduced electrical or motor activity of the large bowel^[16,17]. It must also be taken into account that a further cause of delayed colonic transit may be due to the association with pelvic floor dyssynergia; this condition must be identified, since it is amenable of biofeedback treatment, which can normalize colonic transit^[18].

Table 1 Rome Ⅱ criteria for functional constipation (adapted from reference 4)

However, we still do not know how and why these abnormalities are present in STC patients. In recent years, clinical and manometric evidence has been accumulated that suggests how most of the motility alterations in STC might be considered as a neuropathic type. Moreover, other data showed that some subtle alterations of the enteric nervous system, not evident to conventional histological examination, may be present in these patients. In the present article we will discuss these evidences, and will try to put them in relation with the abnormal motor function of the large bowel documented in this pathological condition.

STC AS A NEUROPATHY: CLINICAL EVIDENCE

In several patients with STC subclinical features of autonomic neuropathy may be present^[19], and other studies described selective sensory and autonomic neuropathy in these subjects^[20], often with a positive family history, suggesting a genetic basis for this condition^[21]. Animal studies might help in elucidating these issues: for instance, transgenic mice with a targeted deletion of neurturin (a neurotrophin) display clinical and tissue phenotype similar to that found in STC, and display associated parasympathetic deficits^[22].

Moreover, since in a sizable proportion of STC patients the symptoms start after pelvic surgical procedures^[23-25] or following childbirth^[26] it has been hypothesized (although the anatomic proof has never been given) that pelvic nerve injury may occur following hysterectomy and childbirth, and that STC could be considered a disorder of pelvic autonomic nerves at least in a subgroup of patients^[27].

STC AS AN ENTERIC NEUROPATHY: INSTRUMENTAL EVIDENCE

Several manometric studies carried out in patients with STC have reported findings that suggest the presence of neuropathic-type abnormalities. Such abnormalities have been described in many instances with respect to the periodic motor activity of the rectosigmoid area (including the so-called rectal motor complex), that appears either decreased or disorganized^[28-30], the contractile colonic motor response following intravenous cholinergic stimulation, that in results impaired^[31], the early motor response following ingestion of a meal, reported as decreased or absent^[32], the overall daily colonic motility, usually decreased to a lesser or greater extent^[33,34], the daily organization of regular contractile colonic patterns, that is often impaired^[35], and the lack of propulsive response to intraluminal instillation of bisacodyl (a powerful stimulant of mass movements in healthy subjects)^[36].

It is worth noting that neuropathic-type abnormalities in patients with STC are not necessarily confined to the large bowel, but may be also documented in other viscera such as the esophagus^[37,38], the stomach^[39,40], the gallbladder^[41], and especially the small bowel^[42-45], suggesting the presence of a pan-enteric motor disorder in these patients, particularly in those with more severe symptoms.

STC AS AN ENTERIC NEUROPATHY: PATHOLOGICAL EVIDENCE

Most of the pathologic descriptions related to STC are pertinent to the large bowel, and only sporadic reports from other gastrointestinal viscera (terminal ileum) exist. Therefore, the discussion of pathological findings will focus on the colonic studies.

Conventional histology

Most studies employing routine light microscopy have failed to identify consistent abnormalities of the enteric nervous system (ENS) in patients with STC^[46-50], apart from the presence of melanosis coli. However, we have recently demonstrated that melanosis coli per se does not have any relationship with colonic ENS abnormalities (in particular with the loss of enteric neurons, as hypothesized in older studies only evaluating the submucosa) in these patients^[51].

Silver staining technique

Morphological abnormalities of colonic innervation have been described in STC patients using the silver staining technique introduced by Smith^[52]. These studies have generally reported a reduction in the total number of argyrophilic neurones and morphological neuronal and/or axonal abnormalities^[53,54]. However, the silver staining technique has been subsequently replaced by more modern and reliable immunohistochemical methods (see below).

Immunohistochemistry

Concerning the hypothesized imbalance of enteric neurotransmitters or the enzyme markers (mostly neuro-peptides) in STC, the various studies (using immuno-staining, immunoassays, or both methods) have frequently yielded inconsistent results. In fact, looking at the findings related to the most commonly investigated neuropeptides (VIP, substance P, neuropeptide Y and 5-HT), decreased, increased or unchanged levels or immunoreactivity has been described in these patients^[55-59]. Overall, on the basis of the above reports it might be stated that it is unlikely that alterations of the enteric neurotransmitterns may play a major role in the pathophysiology of STC. However, more recent observations suggest that an excessive production of nitric oxide in the colonic myenteric plexus of patients with STC could play a pathophysiological role, concurring in the persistent inhibition of contractions^[60,61].

More consistent results have been reported with respect to enteric neurons, interstitial cells of Cajal (ICC), and enteric glial cells (EGC). In fact, a decrease of enteric neural elements (neurons and/or neurofilaments) seems to be a constant feature in studies evaluating patients with STC severe enough to require surgery for symptoms’ relief^[62-66], and these abnormalities are often associated with a reduced number of ICC^[67-71], although this latter finding is not constantly present^[72]. We have recently shown in a relatively large and homogeneous group of patients with severe and intractable STC, compared to age-matched controls, that the ICC are significantly decreased in patients (Figures 1 A and B), that the enteric neuronal loss may be partially due to apoptotic phenomena, and that these patients display a significantly decreased number of EGC with respect to controls (Figures 1 C and D), in both the submucosal and myenteric plexuses^[73].

Figure 1 Interstitial cells of Cajal (arrows) at myenteric plexus level in a control subject (A) and in a patient with slow transit constipation (B). Note the considerable decrease of these cells in the patient (CD117, original magnification x 40). Panels C and D show the enteric glial cells (arrows) in the myenteric plexus of a control and of a patients with slow transit constipation, respectively. Note the important reduction of these cells in the patient, where only a few ones may be identified (S100, original magnification x 40).

STC AS AN ENTERIC NEUROPATHY: CLINICAL, INSUMENTAL, AND PATHOLOGICAL RELATIONSHIPS

On the basis of the above evidences, it seems now possible to track a link between the clinical picture, represented by severe constipation with heavily delayed colonic transit, often refractory to medical treatment, the instrumental manometric findings, that mostly show impaired motility and propulsive activity of the large bowel (sometimes with the participation of the upper gastrointestinal segments too), and the abnormalities of the colonic ENS.

The neuronal loss is likely to affect the motor activity of the large bowel, reducing the likelihood of enteric neurotransmission. This defect is then strengthened by the concomitant reduction of the number of ICC, a cell population of paramount importance for the correct homeostasis of gastrointestinal motility. In fact, the primary role of ICC as intestinal pacemakers has been established in experimental animal models, where it has been shown that a lack of ICC networks leads to the absence of slow waves and is accompanied by delayed or absent intestinal motility^[74,75]. A decreased ICC function might therefore impair the colonic electrical slow wave activity, thereby affecting the contractile response and causing delayed transit in STC patients. In addition, it has been recently demonstrated that in patients with STC the expression of c-kit mRNA and c-kit protein is significantly decreased compared to controls, suggesting that alterations in the c-kit signal pathway may play an important role in ICC reduction in such patients^[76].

An interesting findings, never described before, was the significant decrease of EGC in both the myenteric and submucous plexuses in STC patients compared to controls. This cell population originates from the neural crest and provides both mechanical and physiological support for neuronal elements^[77]. The chief known function of the glia in the adult is the formation of myelin sheaths around axons, allowing the fast connections essential for the nervous system function. Moreover, EGC maintain the appropriate concentrations of ions and neurotransmitters in the neuronal environment and are essential regulators of the formation, maintenance and function of synapses, the key functional units of the nervous system^[78,79]. Since EGC are thought to act as intermediaries in enteric neurotransmission^[80], it is likely that their decrease could synergistically act in further weakening the already precarious neuroenteric balance due to the decrease of neuronal elements and ICC found in patients with STC.

STC AS AN ENTERIC NEUROPATHY: CONCLUSIONS

The case for reclassifying STC other than an “idiopathic” or “functional” disorder is built. In fact, as seen above, clinical, instrumental, and pathological evidences exist that all point toward to a (perhaps) more precise definition of this condition as a true enteric neuropathy. It is probably too early to target STC with a different label, but at least we are now aware of some basic pathophysiological mechanisms potentially responsible for the symptoms and the manometric abnormalities found in this condition. Moreover, apart from mere semantic considerations, the demonstration of such background abnormalities might reveal useful for more targeted therapeutic approaches. For instance, in a mouse model the blockage of Kit receptors caused transdifferentiation of intestinal ICC to a smooth muscle phenotype^[81]: if the same would occur in the human colon and if ICC do not die in STC but rather redifferentiate, it might be possible to create conditions that would shift the phenotype back toward ICC.

In conclusion, the advancement of our knowledge of the possible pathophysological mechanisms of “functional” disorders is important for a more correct clinical and therapeutic approach. Further studies are obviously needed before we can drop the “idiopathic” label from these disorders.

REFERENCES

1     Chang L. Review article: epidemiology and quality of life in functional gastrointestinal disorders. Aliment Pharmacol Ther 2004; 20 Suppl 7: 31-39  PubMed

2     Williams M, Budavari A, Olden KW, Jones MP. Psychosocial assessment of functional gastrointestinal disorders in clinical practice. J Clin Gastroenterol 2005; 39: 847-857  PubMed

3     Corazziari E. Definition and epidemiology of functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2004; 18: 613-631  PubMed

4    Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2: II43-47  PubMed

5     Lembo A, Camilleri M. Chronic constipation. N Engl J Med 2003; 349: 1360-1368  PubMed

6     Prather CM. Subtypes of constipation: sorting out the confusion. Rev Gastroenterol Disord 2004; 4 Suppl 2: S11-S16  PubMed

7     Knowles CH, Martin JE. Slow transit constipation: a model of human gut dysmotility. Review of possible aetiologies. Neurogastroenterol Motil 2000; 12: 181-196  PubMed

8     Bassotti G, Roberto GD, Sediari L, Morelli A. Toward a definition of colonic inertia. World J Gastroenterol 2004; 10: 2465-2467  PubMed

9     Bharucha AE, Phillips SF. Slow transit constipation. Gastroenterol Clin North Am 2001; 30: 77-95  PubMed

10   Bassotti G, de Roberto G, Castellani D, Sediari L, Morelli A. Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol 2005; 11: 2691-2696  PubMed

11   Preston DM, Lennard-Jones JE. Pelvic motility and response to intraluminal bisacodyl in slow-transit constipation. Dig Dis Sci 1985; 30: 289-294  PubMed

12   Kamm MA, van der Sijp JR, Lennard-Jones JE. Observations on the characteristics of stimulated defaecation in severe idiopathic constipation. Int J Colorectal Dis 1992; 7: 197-201  PubMed

13   Bassotti G, Chistolini F, Nzepa FS, Morelli A. Colonic propulsive impairment in intractable slow-transit constipation. Arch Surg 2003; 138: 1302-1304  PubMed

14   Bassotti G, Imbimbo BP, Betti C, Dozzini G, Morelli A. Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol 1992; 87: 504-508  PubMed

15   Bjornsson ES, Chey WD, Hooper F, Woods ML, Owyang C, Hasler WL. Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways. Am J Physiol Gastrointest Liver Physiol 2002; 283: G400-407  PubMed

16   Schang JC, Devroede G, Duguay C, Hemond M, Hebert M. Constipation caused by colonic inertia and distal obstruction: electromyographic study. Gastroenterol Clin Biol 1985; 9: 480-485  PubMed

17   Bassotti G, Gaburri M, Imbimbo BP, Rossi L, Farroni F, Pelli MA, Morelli A. Colonic mass movements in idiopathic chronic constipation. Gut 1988; 29: 1173-1179  PubMed

18   Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology 2005; 129: 86-97  PubMed

19   Altomare D, Pilot MA, Scott M, Williams N, Rubino M, Ilincic L, Waldron D. Detection of subclinical autonomic neuropathy in constipated patients using a sweat test. Gut 1992; 33: 1539-1543  PubMed

20   Raethjen J, Pilot MA, Knowles C, Warner G, Anand P, Williams N. Selective autonomic and sensory deficits in slow transit constipation. J Auton Nerv Syst 1997; 66: 46-52  PubMed

21   Knowles CH, Scott SM, Wellmer A, Misra VP, Pilot MA, Williams NS, Anand P. Sensory and autonomic neuropathy in patients with idiopathic slow-transit constipation. Br J Surg 1999; 86: 54-60  PubMed

22   Heuckeroth RO, Enomoto H, Grider JR, Golden JP, Hanke JA, Jackman A, Molliver DC, Bardgett ME, Snider WD, Johnson EM Jr, Milbrandt J. Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron 1999; 22: 253-263  PubMed

23   Roe AM, Bartolo DC, Mortensen NJ. Slow transit constipation. Comparison between patients with or without previous hysterectomy. Dig Dis Sci 1988; 33: 1159-1163  PubMed

24   Vierhout ME, Schreuder HW, Veen HF. Severe slow-transit constipation following radical hysterectomy. Gynecol Oncol 1993; 51: 401-403  PubMed

25   MacDonald A, Baxter JN, Finlay IG. Idiopathic slow-transit constipation. Br J Surg 1993; 80: 1107-1111  PubMed

26   MacDonald A, Baxter JN, Bessent RG, Gray HW, Finlay IG. Gastric emptying in patients with constipation following childbirth and due to idiopathic slow transit. Br J Surg 1997; 84: 1141-1143  PubMed

27   Knowles CH, Scott SM, Lunniss PJ. Slow transit constipation: a disorder of pelvic autonomic nerves? Dig Dis Sci 2001; 46: 389-401  PubMed

28   Waldron DJ, Kumar D, Hallan RI, Wingate DL, Williams NS. Evidence for motor neuropathy and reduced filling of the rectum in chronic intractable constipation. Gut 1990; 31: 1284-1288  PubMed

29   Bassotti G, Betti C, Pelli MA, Morelli A. Prolonged (24-hour) manometric recording of rectal contractile activity in patients with slow transient constipation. Digestion 1991; 49: 72-77  PubMed

30   Rao SS, Sadeghi P, Batterson K, Beaty J. Altered periodic rectal motor activity: a mechanism for slow transit constipation. Neurogastroenterol Motil 2001; 13: 591-598  PubMed

31   Bassotti G, Chiarioni G, Imbimbo BP, Betti C, Bonfante F, Vantini I, Morelli A, Whitehead WE. Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci 1993; 38: 1040-1045  PubMed

32   Bassotti G, Morelli A, Whitehead WE. Abnormal rectosigmoid myoelectric response to eating in patients with severe idiopathic constipation (slow-transit type). Dis Colon Rectum 1992; 35: 753-756  PubMed

33   Rao SS, Sadeghi P, Beaty J, Kavlock R. Ambulatory 24-hour colonic manometry in slow-transit constipation. Am J Gastroenterol 2004; 99: 2405-2416  PubMed

34   Shafik A, Shafik AA, El-Sibai O, Mostafa RM. Electric activity of the colon in subjects with constipation due to total colonic inertia: an electrophysiologic study. Arch Surg 2003; 138: 1007-1011; discussion 1011  PubMed

35   Bassotti G, Chistolini F, Battaglia E, Chiarioni G, Nzepa FS, Dughera L, deRoberto G, Emanuelli G, Morelli A. Are colonic regular contractile frequency patterns in slow transit constipation a relevant pathophysiological phenomenon? Dig Liver Dis 2003; 35: 552-556  PubMed

36   Bassotti G, Chiarioni G, Germani U, Battaglia E, Vantini I, Morelli A. Endoluminal instillation of bisacodyl in patients with severe (slow transit type) constipation is useful to test residual colonic propulsive activity. Digestion 1999; 60: 69-73  PubMed

37   Watier A, Devroede G, Duranceau A, Abdel-Rahman M, Duguay C, Forand MD, Tetreault L, Arhan P, Lamarche J, Elhilali M. Constipation with colonic inertia. A manifestation of systemic disease? Dig Dis Sci 1983; 28: 1025-1033  PubMed

38   Altomare DF, Portincasa P, Rinaldi M, Di Ciaula A, Martinelli E, Amoruso A, Palasciano G, Memeo V. Slow-transit constipation: solitary symptom of a systemic gastrointestinal disease. Dis Colon Rectum 1999; 42: 231-240  PubMed

39   van der Sijp JR, Kamm MA, Nightingale JM, Britton KE, Granowska M, Mather SJ, Akkermans LM, Lennard-Jones JE. Disturbed gastric and small bowel transit in severe idiopathic constipation. Dig Dis Sci 1993; 38: 837-844  PubMed

40   Mollen RM, Hopman WP, Oyen WJ, Kuijpers HH, Edelbroek MA, Jansen JB. Effect of subtotal colectomy on gastric emptying of a solid meal in slow-transit constipation. Dis Colon Rectum 2001; 44: 1189-1195  PubMed

41   Gunay A, Gurbuz AK, Narin Y, Ozel AM, Yazgan Y. Gallbladder and gastric motility in patients with idiopathic slow-transit constipation. South Med J 2004; 97: 124-128  PubMed

42   Bassotti G, Stanghellini V, Chiarioni G, Germani U, De Giorgio R, Vantini I, Morelli A, Corinaldesi R. Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci 1996; 41: 1999-2005  PubMed

43   Glia A, Lindberg G. Antroduodenal manometry findings in patients with slow-transit constipation. Scand J Gastroenterol 1998; 33: 55-62  PubMed

44   Scott SM, Picon L, Knowles CH, Fourquet F, Yazaki E, Williams NS, Lunniss PJ, Wingate DL. Automated quantitative analysis of nocturnal jejunal motor activity identifies abnormalities in individuals and subgroups of patients with slow transit constipation. Am J Gastroenterol 2003; 98: 1123-1134  PubMed

45   Panagamuwa B, Kumar D, Ortiz J, Keighley MR. Motor abnormalities in the terminal ileum of patients with chronic idiopathic constipation. Br J Surg 1994; 81: 1685-1688  PubMed

46   Preston DM, Hawley PR, Lennard-Jones JE, Todd IP. Results of colectomy for severe idiopathic constipation in women (Arbuthnot Lane’s disease).  1984; 71: 547-552  PubMed

47   Kamm MA, Hawley PR, Lennard-Jones JE. Outcome of colectomy for severe idiopathic constipation. Gut 1988; 29: 969-973  PubMed

48   Walsh PV, Peebles-Brown DA, Watkinson G. Colectomy for slow transit constipation. Ann R Coll Surg Engl 1987; 69: 71-75  PubMed

49   Bassotti G, Betti C, Pelli MA, Morelli A. Extensive investigation on colonic motility with pharmacological testing is useful for selecting surgical options in patients with inertia colica. Am J Gastroenterol 1992; 87: 143-147  PubMed

50   Redmond JM, Smith GW, Barofsky I, Ratych RE, Goldsborough DC, Schuster MM. Physiological tests to predict long-term outcome of total abdominal colectomy for intractable constipation. Am J Gastroenterol 1995; 90: 748-753  PubMed

51   Villanacci V, Bassotti G, Cathomas G, Maurer CA, Di Fabio F, Fisogni S, Cadei M, Mazzocchi A, Salerni B. Is pseudomelanosis coli a marker of colonic neuropathy in severely constipated patients? Histopathology 2006 (in press)

52   Smith B. Myenteric plexus in Hirschsprung’s disease. Gut 1967; 8: 308-312  PubMed

53   Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE 2nd. Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 1985; 88: 26-34  PubMed

54   Zenilman ME, Dunnegan DL, Soper NJ, Becker JM. Successful surgical treatment of idiopathic colonic dysmotility. The role of preoperative evaluation of coloanal motor function. Arch Surg 1989; 124: 947-951  PubMed

55   Koch TR, Carney JA, Go L, Go VL. Idiopathic chronic constipation is associated with decreased colonic vasoactive intestinal peptide. Gastroenterology 1988; 94: 300-310  PubMed

56   Dolk A, Broden G, Holmstrom B, Johansson C, Schultzberg M. Slow transit chronic constipation (Arbuthnot Lane’s disease). An immunohistochemical study of neuropeptide-containing nerves in resected specimens from the large bowel. Int J Colorectal Dis 1990; 5: 181-187  PubMed

57   Lincoln J, Crowe R, Kamm MA, Burnstock G, Lennard-Jones JE. Serotonin and 5-hydroxyindoleacetic acid are increased in the sigmoid colon in severe idiopathic constipation. Gastroenterology 1990; 98: 1219-1225  PubMed

58   Tzavella K, Riepl RL, Klauser AG, Voderholzer WA, Schindlbeck NE, Muller-Lissner SA. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur J Gastroenterol Hepatol 1996; 8: 1207-1211  PubMed

59   Sjolund K, Fasth S, Ekman R, Hulten L, Jiborn H, Nordgren S, Sundler F. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastroenterol Motil 1997; 9: 143-150  PubMed

60   Cortesini C, Cianchi F, Infantino A, Lise M. Nitric oxide synthase and VIP distribution in enteric nervous system in idiopathic chronic constipation. Dig Dis Sci 1995; 40: 2450-2455  PubMed

61   Tomita R, Fujisaki S, Ikeda T, Fukuzawa M. Role of nitric oxide in the colon of patients with slow-transit constipation. Dis Colon Rectum 2002; 45: 593-600  PubMed

62   Schouten WR, ten Kate FJ, de Graaf EJ, Gilberts EC, Simons JL, Kluck P. Visceral neuropathy in slow transit constipation: an immunohistochemical investigation with monoclonal antibodies against neurofilament. Dis Colon Rectum 1993; 36: 1112-1117  PubMed

63   Park HJ, Kamm MA, Abbasi AM, Talbot IC. Immunohistochemical study of the colonic muscle and innervation in idiopathic chronic constipation. Dis Colon Rectum 1995; 38: 509-513  PubMed

64   Porter AJ, Wattchow DA, Hunter A, Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int J Colorectal Dis 1998; 13: 208-216  PubMed

65   Faussone-Pellegrini MS, Infantino A, Matini P, Masin A, Mayer B, Lise M. Neuronal anomalies and normal muscle morphology at the hypomotile ileocecocolonic region of patients affected by idiopathic chronic constipation. Histol Histopathol 1999; 14: 1119-1134  PubMed

66   Wedel T, Roblick UJ, Ott V, Eggers R, Schiedeck TH, Krammer HJ, Bruch HP. Oligoneuronal hypoganglionosis in patients with idiopathic slow-transit constipation. Dis Colon Rectum 2002; 45: 54-62  PubMed

67   He CL, Burgart L, Wang L, Pemberton J, Young-Fadok T, Szurszewski J, Farrugia G. Decreased interstitial cell of cajal volume in patients with slow-transit constipation. Gastroenterology 2000; 118: 14-21  PubMed

68   Lyford GL, He CL, Soffer E, Hull TL, Strong SA, Senagore AJ, Burgart LJ, Young-Fadok T, Szurszewski JH, Farrugia G. Pan-colonic decrease in interstitial cells of Cajal in patients with slow transit constipation. Gut 2002; 51: 496-501  PubMed

69   Wedel T, Spiegler J, Soellner S, Roblick UJ, Schiedeck TH, Bruch HP, Krammer HJ. Enteric nerves and interstitial cells of Cajal are altered in patients with slow-transit constipation and megacolon. Gastroenterology 2002; 123: 1459-1467  PubMed

70   Tong WD, Liu BH, Zhang LY, Zhang SB, Lei Y. Decreased interstitial cells of Cajal in the sigmoid colon of patients with slow transit constipation. Int J Colorectal Dis 2004; 19: 467-473  PubMed

71   Lee JI, Park H, Kamm MA, Talbot IC. Decreased density of interstitial cells of Cajal and neuronal cells in patients with slow-transit constipation and acquired megacolon. J Gastroenterol Hepatol 2005; 20: 1292-1298  PubMed

72   Toman J, Turina M, Ray M, Petras RE, Stromberg AJ, Galandiuk S. Slow transit colon constipation is not related to the number of interstitial cells of Cajal. Int J Colorectal Dis 2005; 1-6  PubMed

73   Bassotti G, Villanacci V, Maurer CA, Fisogni S, Di Fabio F, Cadei M, Morelli A, Panagiotis T, Cathomas G, Salerni B. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut 2006; 55: 41-46  PubMed

74   Ward SM, Burns AJ, Torihashi S, Sanders KM. Mutation of the proto-oncogene c-kit blocks development of interstitial cells and electrical rhythmicity in murine intestine. J Physiol 1994; 480 ( Pt 1): 91-97  PubMed

75   Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature 1995; 373: 347-349  PubMed

76   Tong WD, Liu BH, Zhang LY, Xiong RP, Liu P, Zhang SB. Expression of c-kit messenger ribonucleic acid and c-kit protein in sigmoid colon of patients with slow transit constipation. Int J Colorectal Dis 2005; 20: 363-367  PubMed

77   Ruhl A. Glial cells in the gut. Neurogastroenterol Motil 2005; 17: 777-790  PubMed

78   Gershon MD, Rothman TP. Enteric glia. Glia 1991; 4: 195-204  PubMed

79   Jessen KR. Glial cells. Int J Biochem Cell Biol 2004; 36: 1861-1867  PubMed

80   Ruhl A, Nasser Y, Sharkey KA. Enteric glia. Neurogastroenterol Motil 2004; 16 Suppl 1: 44-49  PubMed

81   Torihashi S, Nishi K, Tokutomi Y, Nishi T, Ward S, Sanders KM. Blockade of kit signaling induces transdifferentiation of interstitial cells of cajal to a smooth muscle phenotype. Gastroenterology 1999; 117: 140-148  PubMed

S- Editor Wang J L- Editor Chiarioni G E- Editor Ma WH